4//SEC Filing
Angelino Mark D. 4
Accession 0001415889-21-000350
CIK 0001733294other
Filed
Jan 19, 7:00 PM ET
Accepted
Jan 20, 4:05 PM ET
Size
15.5 KB
Accession
0001415889-21-000350
Insider Transaction Report
Form 4
Angelino Mark D.
Chief Operating Officer
Transactions
- Exercise/Conversion
Common Stock
2021-01-15$4.59/sh+7,500$34,425→ 353,137 total - Sale
Common Stock
2021-01-15$32.29/sh−3,500$113,015→ 349,637 total - Sale
Common Stock
2021-01-15$34.12/sh−500$17,060→ 346,237 total - Sale
Common Stock
2021-01-15$34.96/sh−600$20,976→ 345,637 total - Exercise/Conversion
Stock Option (right to buy)
2021-01-15−7,500→ 110,960 totalExercise: $4.59Exp: 2028-04-01→ Common Stock (7,500 underlying) - Sale
Common Stock
2021-01-15$33.18/sh−2,900$96,222→ 346,737 total
Holdings
- 169,846(indirect: See footnote)
Common Stock
Footnotes (7)
- [F1]These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 20, 2020.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.70 to $32.68, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (5) of this Form 4.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.72 to $33.69, inclusive.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.75 to $34.56, inclusive.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.79 to $34.99, inclusive.
- [F6]The securities are directly held by the Mark D. Angelino 2020 Qualified Annuity Trust, or the Trust. Mark D. Angelino is the settlor and trustee of the Trust, and the Trust is for the benefit of Elizabeth I., Emily A., John P., and Matthew R. Angelino. The reporting person may be deemed to beneficially own the shares of common stock owned by the Trust.
- [F7]The option to purchase 123,761 shares was granted on April 2, 2018. The shares underlying the option vest over four years, with 25% of the shares vested on April 2, 2019 and the remaining shares vesting in equal quarterly installments thereafter.
Documents
Issuer
Generation Bio Co.
CIK 0001733294
Entity typeother
Related Parties
1- filerCIK 0001814308
Filing Metadata
- Form type
- 4
- Filed
- Jan 19, 7:00 PM ET
- Accepted
- Jan 20, 4:05 PM ET
- Size
- 15.5 KB